Corbus Pharmaceuticals Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CRBP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
08 Mar 24	BuyUS$23,327,560	Cormorant Asset Management, LP	Company	550,000	US$45.96
02 Feb 24	BuyUS$14,250,000	Cormorant Asset Management, LP	Company	750,000	US$19.00
26 Jan 24	BuyUS$9,111,941	Cormorant Asset Management, LP	Company	282,632	US$38.49

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 149.3%.

Top 25 shareholders own 61.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.3%	Cormorant Asset Management, LP	2,025,000	US$75.4m	0%	3.91%
7.58%	Adage Capital Management, L.P.	796,392	US$29.7m	0%	0.05%
5.18%	Millennium Management LLC	544,276	US$20.3m	0%	0.02%
4.09%	RA Capital Management, L.P.	430,182	US$16.0m	0%	0.2%
4.06%	Tang Capital Management, LLC	426,220	US$15.9m	0%	1.67%
3.8%	Paradigm Biocapital Advisors LP	399,658	US$14.9m	0%	0.7%
3.7%	Point72 Asset Management, L.P.	388,676	US$14.5m	0%	0.03%
3.26%	K2 Healthventures Equity Trust LLC	342,113	US$12.7m	0%	no data
2.47%	Assenagon Asset Management S.A.	259,456	US$9.7m	0%	0.02%
1.86%	Ikarian Capital, LLC	195,899	US$7.3m	0%	1.73%
1.71%	The Vanguard Group, Inc.	179,456	US$6.7m	0%	no data
1.43%	Sio Capital Management, LLC	150,000	US$5.6m	0%	2.06%
0.77%	BlackRock, Inc.	81,065	US$3.0m	-0.15%	no data
0.4%	Boothbay Fund Management, LLC	41,615	US$1.6m	0%	0.06%
0.36%	Geode Capital Management, LLC	38,145	US$1.4m	2.59%	no data
0.36%	Healthinvest Partners AB	38,000	US$1.4m	0%	0.52%
0.21%	Royal Bank of Canada, Banking & Securities Investments	22,098	US$823.1k	1,580%	no data
0.16%	Dimensional Fund Advisors LP	16,692	US$621.8k	-42.9%	no data
0.13%	State Street Global Advisors, Inc.	13,179	US$490.9k	0%	no data
0.099%	Yuval Cohen	10,453	US$389.4k	219%	no data
0.087%	Cambridge Investment Research Advisors, Inc.	9,182	US$342.0k	0%	no data
0.08%	Sean Moran	8,429	US$314.0k	26.9%	no data
0.049%	abrdn plc	5,143	US$191.6k	0%	no data
0.046%	Charles Schwab Investment Management, Inc.	4,813	US$179.3k	45.3%	no data
0.032%	FMR LLC	3,353	US$124.9k	0%	no data